Autopsy report · NCT00852046

Adjunct Dexmedetomidine (Precedex®) Therapy Impact on Sedative and Analgesic Requirement

“PI resigned.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 4

Sponsor

Avera McKennan Hospital & University Health Center

Sponsor type

University, hospital or other

Conditions

Sedation; Analgesia

Interventions

Dexmedetomidine

Participants

0

Trials that died the same way

• Treatment of Chorioamnionitis After Delivery
  “PI retired” (77% match in meaning)
• Mechanical Ventilation in Severe Brain Injury: The Effect of Positive End Expiratory Pressure on Intracranial Pressure
  “Departure of PI” (76% match in meaning)
• Use of Levemir® Improves Metabolic and Clinical Status in Cystic Fibrosis-related Diabetes (CFRD)
  “PI left the institution” (76% match in meaning)
• Conventionally vs. Digitally Fabricated Complete Dentures: Clinical Treatment Outcome Differences
  “The PI is deceased, decision was made to withdraw.” (75% match in meaning)
• Protection From Cisplatin Ototoxicity by Lactated Ringers
  “PI left the university.” (74% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.